access to national-level pharmaceutical sales data and International level sales data to estimate and forecast trends in pharmaceutical sales, pricing, and volume of distribution throughout various settings of care.

FDA/CDER requires access to national-level pharmaceutical sales data and international-level pharmaceutical sales data to estimate and forecast trends in pharmaceutical sales, pricing, and volume of distribution throughout various settings of care. Continued access to these data allows the FDA to respond expeditiously to questions relating to drug safety, the impact of regulatory policies, and to potential drug shortage situations, helping the Agency to make more informed decisions about matters that affect the health of Americans. See Attachments for RFP and related attachments. Modification: See attachment for Contractor Questions and Government Responses. Bassed on the Contractor Questions, the Description Title for this requirement has been updated and the Solictation Document has been updated. Please see the document "Solcitation updated 9 1 2022..."